PharmacoEconomics Journal Issues Research Articles in Vol. 40, No. 4
April 14, 2022
April 14, 2022
BASEL, Switzerland, April 14 -- PharmacoEconomics, a peer-reviewed journal that says it features application of pharmacoeconomics and quality-of-life assessment to optimum drug therapy and health outcomes, published research articles on the following topics in its Vol. 40, No. 4 edition:
* Cost-Effectiveness Analysis of Herpes Zoster Vaccination in 50- to 85-Year-Old Immunocompetent Belgian Cohorts: A Comparison between No Vaccination, the Adjuvanted Subunit Vaccine, and Live-Attenu . . .
* Cost-Effectiveness Analysis of Herpes Zoster Vaccination in 50- to 85-Year-Old Immunocompetent Belgian Cohorts: A Comparison between No Vaccination, the Adjuvanted Subunit Vaccine, and Live-Attenu . . .